Baudax Bio, Inc.
Baudax Bio, Inc. (BXRXQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BXRXQ · as of Jun 8, 2026
Key Statistics
Explore Baudax Bio, Inc. Data
bxrxq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
bxrxq competitorsBXRXQ
ARNI
CALA
FPMI
IVBT
KLDOStock Performance
Full HistoryAbout Baudax Bio, Inc.
Baudax Bio, Inc. a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management …
what is baudax bio, inc. · bxrxq stock overview · baudax bio, inc. company profile · who is baudax bio, inc. ceo · bxrxq OTC · baudax bio, inc. headquarters · baudax bio, inc. business segments
About Stock Overview & Key Data
Baudax Bio, Inc. (BXRXQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 21, 2024. As of the latest trading session, BXRXQ stock price is $0.00, with a market capitalization of $4,359. The stock has returned +900.00% over the past 12 months and +900.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Baudax Bio, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Baudax Bio, Inc. reported revenue of $1.3M and net income of -$58.8M. For detailed data — including Baudax Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Baudax Bio, Inc. (BXRXQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol BXRXQ. The 52-week range is $0.00 – $0.00.